Analyst Ratings for ARS Pharmaceuticals Inc (SPRY)
SPRY Rating Summary
SPRY Price Target Summary
- Highest: $34.00 (Raymond James)
- Lowest: $25.00 (Northland)
- Average: $29.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$29.00 (+231.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$29.00 (+231.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/9/2026 | Northland | Carl Byrnes Jr. | New Coverage | Outperform (N/A) |
25.00 (N/A) |
8.19 (8.75) |
6.84% | Details |
| 11/4/2025 | Roth/MKM | Kyle Bauser | New Coverage | Buy (N/A) |
30.00 (N/A) |
8.62 (8.75) |
1.51% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
